Follow
Joe M. O'Sullivan
Joe M. O'Sullivan
Professor of Radiation Oncology., Queen's University Belfast
Verified email at qub.ac.uk - Homepage
Title
Cited by
Cited by
Year
Alpha emitter radium-223 and survival in metastatic prostate cancer
C Parker, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, SD Fossň, ...
New England Journal of Medicine 369 (3), 213-223, 2013
37172013
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistageá…
ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ...
The Lancet 387 (10024), 1163-1177, 2016
21082016
Abiraterone for prostate cancer not previously treated with hormone therapy
ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ...
New England Journal of Medicine 377 (4), 338-351, 2017
17882017
Gold nanoparticles as novel agents for cancer therapy
S Jain, DG Hirst, JM O'Sullivan
The British journal of radiology 85 (1010), 101-113, 2012
12622012
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
D Dearnaley, I Syndikus, H Mossop, V Khoo, A Birtle, D Bloomfield, ...
The Lancet Oncology 17 (8), 1047-1060, 2016
12572016
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
CC Parker, ND James, CD Brawley, NW Clarke, AP Hoyle, A Ali, ...
The Lancet 392 (10162), 2353-2366, 2018
11042018
Radiation-induced bystander signalling in cancer therapy
KM Prise, JM O'sullivan
Nature Reviews Cancer 9 (5), 351-360, 2009
9022009
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blindá…
O Sartor, R Coleman, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, ...
The Lancet Oncology 15 (7), 738-746, 2014
5622014
Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies
S Jain, JA Coulter, AR Hounsell, KT Butterworth, SJ McMahon, ...
International Journal of Radiation Oncology* Biology* Physics 79 (2), 531-539, 2011
5552011
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: aá…
P Hoskin, O Sartor, JM O'Sullivan, DC Johannessen, SI Helle, J Logue, ...
The Lancet Oncology 15 (12), 1397-1406, 2014
4862014
Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles
SJ McMahon, WB Hyland, MF Muir, JA Coulter, S Jain, KT Butterworth, ...
Scientific reports 1 (1), 18, 2011
4622011
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours
JM O’sullivan, RA Huddart, AR Norman, J Nicholls, DP Dearnaley, ...
Annals of Oncology 14 (1), 91-96, 2003
4272003
Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
NW Clarke, A Ali, FC Ingleby, A Hoyle, CL Amos, G Attard, CD Brawley, ...
Annals of Oncology 30 (12), 1992-2003, 2019
3762019
Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
3672020
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
F Saad, J Carles, S Gillessen, A Heidenreich, D Heinrich, J Gratt, J LÚvy, ...
The Lancet Oncology 17 (9), 1306-1316, 2016
3152016
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
CC Parker, NW Clarke, AD Cook, HG Kynaston, PM Petersen, C Catton, ...
The Lancet 396 (10260), 1413-1421, 2020
3092020
Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy
B Nugent, S Lewis, JM O'Sullivan
Cochrane Database of Systematic Reviews, 2013
2802013
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
MR Sydes, MR Spears, MD Mason, NW Clarke, DP Dearnaley, ...
Annals of Oncology 29 (5), 1235-1248, 2018
2732018
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomisedá…
G Attard, L Murphy, NW Clarke, W Cross, RJ Jones, CC Parker, ...
The lancet 399 (10323), 447-460, 2022
2452022
Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy
SJ McMahon, WB Hyland, MF Muir, JA Coulter, S Jain, KT Butterworth, ...
Radiotherapy and Oncology 100 (3), 412-416, 2011
2382011
The system can't perform the operation now. Try again later.
Articles 1–20